Aurobindo Pharma | ARBP - Sales Revenues

Stock Price
1,187.65
Daily Change
5.15 0.44%
Monthly
-3.86%
Yearly
-0.34%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR82.86B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Cipla INR 75.18B 710M Dec/2025
Divis Laboratories Ltd INR 27.15B 3.05B Sep/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Hindustan Unilever INR 155.85B 5.93B Sep/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025